The European Commission has featured MES-CoBraD as a success story on its Research and Innovation website. The article describes how the project helps clinicians diagnose and treat complex brain disorders such as dementia, epilepsy, and sleep apnoea.
This year's World Brain Day is the first one after the completion of the MES-CoBraD project. So it was apt that the new article posted by HaDEA for the day mentions our project, its focus, and the work that was conducted.
Curious about the future of brain disorder diagnosis and treatment? The MES-CoBraD project has leveraged real-world data to break new ground in medical understanding of complex brain disorders. In this Horizon Europe project webinar, our experts will share key insights and the latest advances in technology and medicine. Don’t miss this opportunity – register here.
Brain disorders include disabilities that stem from brain dysfunction, including neurological (Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, stroke, epilepsy and seizures, etc.), sleep disorders, and mental health disorders (depression, anxiety, etc.). Brain disorders interfere with activities of daily living and worsen quality of life, and are often associated with social stigma.
On 20/11/23, the MES-CoBraD project partnered RETENTION and RE-SAMPLE for a second online event – view the first event here. RETENTION and Re-SAMPLE are both HORIZEON2020 projects from the same funding stream as MES-CoBraD. The three projects all tackle medical issues with the innovative use of real-world data. In the webinar, representatives from each project highlight potential of Real-World Data (RWD) in advancing medical research and healthcare.
On 27/09/23, members of the MES-CoBraD consortium presented the projects work in an online event. If you missed this session, we now have the recording for you watch again!
The event introduced the MES-CoBraD platform and demonstrated its potential for three key stakeholder groups: clinicians, researchers, and patients. This user angle highlights the capabilities of MES-CoBraD and the potential of this new tool designed to support clinical practice and research.
Watch the session below:
